Dow Up 0.81% Nasdaq Up 1.25%

CytRx Corporation (CYTR)

-NasdaqCM
2.89 Up 0.05(1.70%) 9:46AM EDT - Nasdaq Real Time Price
Prev Close:2.84
Open:2.94
Bid:2.90 x 4700
Ask:2.92 x 300
1y Target Est:11.00
Beta:0.86
Next Earnings Date:N/A
Day's Range:2.84 - 2.94
52wk Range:2.00 - 8.35
Volume:101,544
Avg Vol (3m):826,767
Market Cap:161.03M
P/E (ttm):N/A
EPS (ttm):-1.09
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

» More Headlines for CYTR

Comparison

Symbol% ChgMkt Cap
CYTRUp 1.70%161.03M
LLYUp 0.16%71.89B
NVSUp 0.64%224.52B
SNYUp 0.64%120.69B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):1,583.30
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :-0.70
Quarterly EPS Est (Sep-14) :-0.25
Mean Recommendation*:2.0
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

CytRx Corporation operates as a biopharmaceutical research and development company specializing in oncology. The company’s product candidate includes aldoxorubicin that has completed Phase IIb clinical trial as a first-line therapy for soft t... View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback